Metastatic Hr Positive Her2 Negative Breast Cancer clinical trials

Explore recruiting metastatic hr positive her2 negative breast cancer clinical trials.

Recruiting metastatic hr positive her2 negative breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Hr Positive Her2 Negative Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, 2-arm, open-label, phase II study of abemaciclib combined with endocrine therapy (letrozole or fulvestrant) with or without a short course of induction chemotherapy with paclitaxel as first-line therapy in patients with unresectable locally advanced or metastatic HR-positive/HER2-negative breast cancer with aggressive disease criteria. (ABIGAIL)

Spain, Portugal, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Discontinuation of CDK4/6 inhibitors in patients with metastatic HR positive, HER2 negative breast cancer with durable disease control: A randomized low-intervention phase II trial of the AIO working groups breast cancer and quality of life

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Hr Positive Her2 Negative Breast Cancer trials by city

Metastatic Hr Positive Her2 Negative Breast Cancer in Toronto Metastatic Hr Positive Her2 Negative Breast Cancer in Vancouver Metastatic Hr Positive Her2 Negative Breast Cancer in Montreal Metastatic Hr Positive Her2 Negative Breast Cancer in Calgary Metastatic Hr Positive Her2 Negative Breast Cancer in Edmonton Metastatic Hr Positive Her2 Negative Breast Cancer in Ottawa Metastatic Hr Positive Her2 Negative Breast Cancer in Winnipeg Metastatic Hr Positive Her2 Negative Breast Cancer in Quebec City Metastatic Hr Positive Her2 Negative Breast Cancer in Hamilton Metastatic Hr Positive Her2 Negative Breast Cancer in Kitchener Metastatic Hr Positive Her2 Negative Breast Cancer in London Metastatic Hr Positive Her2 Negative Breast Cancer in Halifax Metastatic Hr Positive Her2 Negative Breast Cancer in New York Metastatic Hr Positive Her2 Negative Breast Cancer in Los Angeles Metastatic Hr Positive Her2 Negative Breast Cancer in Chicago Metastatic Hr Positive Her2 Negative Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease